InnoCare receives China NMPA approval for phase III trial of mesutoclax with azacitidine versus venetoclax with azacitidine to treat naive AML: Beijing Thursday, August 20, 2026, ...
Mankind Pharma enters into in-licensing agreement with Chongqing Chenan Biopharma: Our Bureau, Mumbai Thursday, August 20, 2026, 15:10 Hrs [IST] Mankind Pharma Limited, one of Ind ...
BillionToOne’s cell-free DNA testing provides new evidence supporting routine use of cfDNA fetal risk assessment in general-risk pregnancies: Menlo Park, California Thursday, Au ...
AIVITA Biomedical appoints global health and vaccine readiness leader, Larry Brilliant to board of directors: Irvine, California Thursday, August 20, 2026, 17:30 Hrs [IST] AIVITA ...
OmniActive launches Fenavari, a clinically studied botanical solution for women’s midlife health: Our Bureau, Mumbai Thursday, August 20, 2026, 17:25 Hrs [IST] OmniActive Health ...
Immunocine Cancer Center opens second treatment centre in Cabo San Lucas, expands personalized dendritic cell therapy: Houston Thursday, August 20, 2026, 16:00 Hrs [IST] Respondin ...
Karnataka health minister UT Khader said that the recent state FSDA (Food Safety Drugs Administration) inspection drive seizing spurious medicines of Rs. 4.91 crore value is a national-level network.
IPGA TN branch to release IPC 2026 brochure in Chennai ahead of national mega event: Our Bureau, Chennai Thursday, August 20, 2026, 16:30 Hrs [IST] The Tamil Nadu state branch of ...
Dr Reddy’s Labs receives 4 observations from US FDA for formulations facility in Hyderabad: Our Bureau, Mumbai Thursday, August 20, 2026, 14:50 Hrs [IST] Dr. Reddy's Laboratorie ...
Lupin partners with Tenpoint Therapeutics to commercialize Yuvezzi: Our Bureau, Mumbai Thursday, August 20, 2026, 16:15 Hrs [IST] Global pharma major Lupin Limited announced that ...
Novartis to present data from 10 abstracts across its cardiovascular portfolio at ESC Congress 2026: Basel Thursday, August 20, 2026, 14:00 Hrs [IST] Novartis will present data fr ...
Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses: Columbus, Ohio Thursday, August 20, 2026, 11:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results